Memorandum to All Behavioral Health Treatment Programs - From Renee Webster, Assistant Director, OHCQ and Kathleen Rebbert-Frankling, Acting Director, ADAA - Regarding: Point of Care Toxicology Testing (April 4, 2013)
Although the following paragraph is mention in the letter blast, many phone calls have been received asking which two applications are required.
- The program must complete two applications: A State Compliance Application requesting a Letter of Exception and an application for a CLIA (Clinical Laboratory Improvement Amendments) certificate of waiver for the Department of Health and Human Services, Center for Medicaid and Medicare Services (CMS). The applications can be obtained at www.dhmh.maryland.gov/ohcq/.
For convenience sake, the two applications are listed below. On the CLIA application you need to select CLIA waiver on the first page. On the state application use schedule B on the test menu page and select the checkbox - Urine or saliva drug or alcohol for approved counselors.
Per the new regs the named director on both of the applications should meet the following:
C) Be clinical staff who:
(i) Meets the qualifications set for in COMAR 10.47.01.06D;
(ii) Is employed by a substance abuse treatment program that is certified or accredited in accordance with COMAR 10.47.04.03; and
(iii) Is authorized to order tests to detect the presence of controlled dangerous substances on patients enrolled in the substance abuse treatment program.
Instructions for Completion of State Compliance Application
Clinical Laboratory Improvement Amendments (CLIA) Application for Certification
** Please mail both completed applications along with the director's diploma and copy of current license to:
Lab Licensing Department
55 Wade Avenue, Bland Bryant Building
Catonsville, MD 21228
